Cargando…
Tumor-Targeting Polymer–Drug Conjugate for Liver Cancer Treatment In Vitro
Bufalin (buf) has poor solubility in aqueous solution, poor tumor targeting, and many non-specific toxic and side effects. The advantages of high-molecular-weight polymer conjugates are that they can improve the water solubility of buf, prolong plasma half-life, and reduce non-specific toxicity. A n...
Autores principales: | Xu, Jiankun, Lin, Shanmeng, Hu, Hao, Xing, Qi, Geng, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653589/ https://www.ncbi.nlm.nih.gov/pubmed/36365509 http://dx.doi.org/10.3390/polym14214515 |
Ejemplares similares
-
Functional cRGD-Conjugated Polymer Prodrug for Targeted
Drug Delivery to Liver Cancer Cells
por: Zhou, Ru, et al.
Publicado: (2022) -
Covalent Polymer-Drug Conjugates
por: Elvira, Carlos, et al.
Publicado: (2005) -
Anticancer nanoparticulate polymer‐drug conjugate
por: Feng, Quanyou, et al.
Publicado: (2016) -
DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis
por: Wu, Yangping, et al.
Publicado: (2023) -
Tumor Targeting with an isoDGR–Drug Conjugate
por: Zanella, Simone, et al.
Publicado: (2017)